Colchicine for long-term management of acute coronary syndromes

Randomised controlled trials support the use of low-dose colchicine in patients who have had a recent myocardial infarction or have coronary artery diseaseNidorf, 2020Tardif, 2019. However, the role of colchicine in long-term management of acute coronary syndromes in clinical practice is uncertain and still evolving. It may be considered when guided by a specialist, particularly in patients whose other risk factors are insufficiently controlled or if recurrent cardiovascular events have occurred.

If colchicine is considered appropriate for long-term management of acute coronary syndromes, use: